BlackRock, Inc. 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
10,473,250 9.200% |
0 (Unchanged) |
Filing |
| 2024-10-21 4:11 pm Sale |
2024-09-30 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
10,473,250 9.200% |
-739,566 (-6.60%) |
Filing |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
11,212,816 11.400% |
1,486,921 (+15.29%) |
Filing |
| 2023-01-06 12:23 pm Purchase |
2022-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
9,725,895 10.000% |
2,665,343 (+37.75%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
7,060,552 7.400% |
389,011 (+5.83%) |
Filing |
| 2021-01-29 09:57 am Purchase |
2020-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
6,671,541 7.600% |
878,854 (+15.17%) |
Filing |